Preoperative Radiotherapy Improves Survival for Patients Undergoing Total Mesorectal Excision for Stage T3 Low Rectal Cancers
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 236 (2) , 203-207
- https://doi.org/10.1097/00000658-200208000-00008
Abstract
To examine the effect of preoperative radiotherapy (PRT) on patients who undergo rectal resection with total mesorectal excision (TME) for stage T3 low rectal cancers. Evidence for the value of PRT before rectal cancer surgery is weakened by variability in the use of TME. Many surgeons have concluded that PRT is unnecessary for small rectal tumors if TME is performed, but there are no prospective data to support this opinion. Since 1980, 2,200 patients with rectal cancer have been enrolled in a prospective database. Of these, 259 underwent curative anterior or abdominoperineal resection with TME for pathologically confirmed T3 lesions within 8 cm of the anal verge. Patients were grouped by receiving PRT (n = 92) or not receiving PRT (n = 167). Five-year overall survival and 5-year local recurrence rates were evaluated. Overall survival was increased from 52% in patients not receiving PRT to 63% in those receiving PRT. PRT increased overall survival for node-negative patients from 58% to 82%, with no benefit for node-positive patients. There was no significant difference in local recurrence rates. When categorized by tumor size, there was no difference in overall survival or local recurrence for 0- to 2-cm tumors or those larger than 5 cm, but PRT increased overall survival from 50% to 72% for patients with 2- to 5-cm tumors. Similar results were observed for patients with tumors staged as T3 on preoperative endoluminal ultrasound. Patients with pT3 low rectal cancers undergoing resection with TME have an improved survival with PRT. The effect is most beneficial for patients with node-negative and 2- to 5-cm tumors, although this group may include larger and node-positive tumors that have been downstaged by PRT. PRT should be advocated for all patients with T3 rectal cancers less than 8 cm from the anal verge, even if the surgery includes a properly performed TME.Keywords
This publication has 20 references indexed in Scilit:
- Preoperative staging of rectal cancer allows selection of patients for preoperative radiotherapyBritish Journal of Surgery, 2000
- Total Mesorectal Excision (TME) with or without Preoperative Radiotherapy in the Treatment of Primary Rectal Cancer: Prospective Randomised Trial with Standard Operative and Histopathological TechniquesBritish Journal of Surgery, 1999
- Impact of surgeon's technique on outcome after treatment of rectal carcinomaDiseases of the Colon & Rectum, 1999
- Total mesorectal excision is not necessary for cancers of the upper rectumSurgery, 1998
- Rectal CancerArchives of Surgery, 1998
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failureEuropean Journal Of Cancer, 1994
- Adjuvant preoperative radiotherapy for locally advanced rectal carcinomaDiseases of the Colon & Rectum, 1994
- Adjuvant therapy of colorectal cancer. Why we still don't knowPublished by American Medical Association (AMA) ,1988
- RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCERThe Lancet, 1986